Akut mieloid leukémia (AML): vizsgálatok itt: Japán
9 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleBleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
- Where
- Bunkyō City, Chūōku, Maebashi, Nagasaki, Nagoya, Okayama, Tokushima, Yamagata, Yoshida
- Életkor
- 18 év and over
- People
- 875 worldwide
- Run by
- Stichting Hemato-Oncologie voor Volwassenen Nederland
See details and how to joinNCT07223814 · EU 2025-522767-15-00 - 1. fázisCsak meghívásosA Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
- Where
- Nagoya, Tokyo
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06788509 · EU 2024-515457-21-00 - 3. fázisTaking peopleA Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
- Where
- Bunkyō City, Fukuoka, Fukushima, Gifu, Kanazawa, Kobe, Kumamoto, Maebashi, Nagoya, Okayama, Osaka, Sapporo, Sendai, Tokyo, Tsukuba, Yamagata, Yoshida
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06852222 · EU 2024-520154-38-00 - 3. fázisTaking peopleMocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
- Where
- Anjo-shi, Fukuoka, Hiroshima, Kanazawa, Kobe, Kōtoku, Matsuyama, Nagoya, Okayama, Osaka, Saitama, Sapporo, Shimotsuke-shi, Tokyo, Yufu
- Életkor
- 18 év to 75 év
- People
- 366 worldwide
- Run by
- Priothera SAS
See details and how to joinNCT05429632 - 1/2. fázisTaking peopleStudy of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
- Where
- Bunkyō City, Kashiwa, Okayama
- Életkor
- 16 év and over
- People
- 85 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07155226 · EU 2025-521299-76-00 - 1. fázisTaking peoplePhase I Clinical Trial of KK2845 in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Other Hematologic Malignancies.
- Where
- Fukuoka, Fukushima, Hirakata, Kamogawa, Kanazawa, Kurume, Mibu, Musashino, Nagasaki, Okayama, Osaka, Saitama, Sapporo, Tokyo, Yoshida
- Életkor
- 18 év and over
- People
- 156
- Run by
- Kyowa Kirin Co., Ltd.
See details and how to joinNCT06812104 - 2. fázisTaking peopleA Phase 2 Clinical Study of Ziftomenib in Patients With Relapsed or Refractory NPM1-Mutated Acute Myeloid Leukemia
- Where
- Chiba, Gifu, Hyōgo, Ibaraki, Kagoshima, Kanagawa, Kyoto, Miyagi, Nagano, Nagasaki, Okayama, Osaka, Saitama, Tochigi, Tokyo
- Életkor
- 18 év and over
- People
- 6
- Run by
- Kyowa Kirin Co., Ltd.
See details and how to joinNCT07623616 - 2. fázisTaking peopleA Clinical Trial of Olutasidenib in Patients With Acute Myeloid Leukemia
- Where
- Tokyo and Other Japanese Cities
- Életkor
- 18 év and over
- People
- 3
- Run by
- Kissei Pharmaceutical Co., Ltd.
See details and how to joinNCT07604064 - 1/2. fázisTaking peopleA Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Where
- Bunkyō City, Bunkyo-ku, Fukuoka, Fukushima, Hokkaido, Isehara-Shi, Kashiwa-shi, Miyagi, Nagasaki, Okayama, Osaka, Yoshida-gun
- Életkor
- 12 év and over
- People
- 606 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555